Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: Differential effects on production and allele frequencies

Genes and Immunity

Volumn 1, Issue 3, 2000, Pages 185-190

  Koss, Konrad ^a,b,c   Satsangi, J ^a   Fanning, G C ^c   Welsh, K I ^c   Jewell, D P ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Crohn's disease; IL 10; LT ; Polymerase chain reaction; TNF ; Ulcerative colitis

Indexed keywords

CYTOKINE; INTERLEUKIN 10; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SMOKING; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; FEMALE; GENE FREQUENCY; HUMANS; INTERLEUKIN-10; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034139448     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363657     Document Type: Article

References (28)

1. De Waal Malefyt R, Abrams J, Bennett B et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An auto-regulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
2. Fiorentino DF, Zlotnik A, Mosmann TR et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 146: 3445-3451.
3. Takeshita S, Gage JR, Kishimoto T et al. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 1996; 156: 2591-2598.
4. Koss K, Sutton M, Welsh KI. Flow cytometric analysis of TNFα and IL-10 expression on leucocytes in whole blood. Genes and Immunity (submitted for publication).
5. Donnelly RP, Freeman SL, Hayes MP. Inhibition of IL-10 expression by INF-gamma up-regulates transcription of TNF-alpha in human monocytes. J Immunol 1995; 155: 1420-1427.
6. Entzian P, Linnemann K, Schlaak M, Zabel P. Obstructive spleen apnea syndrome and circulating rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996; 153: 1080-1086.
7. Westendorp RG, Langermans JA, Huizinga TW et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-173.
8. Van Dullemen HM, Van Deventer SJH, Hommes DW et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129-135.
9. Kuhn R, Lohler J, Rennick D et al. Interleukine-10 deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274.
10. Kucharzik T, Stroll R, Lugering N, Domscheke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease. Clin Exp Immunol 1995; 100: 452-456.
11. De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1β, TNFα, IL-6, IL-2, INFγ, and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4: 239-248.
12. Van Zee KJ, Kohno T, Fischer E et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89: 4845-4849.
13. Terashima T, Soejima K, Waki Y et al. Neutrophils activated by granulocytes colony-stimulating factor suppress tumor necrosis factor-alpha release from monocytes stimulated by endotoxin. Am J Respir Cell Mol Biol 1995; 13: 69-73.
14. Lien E, Liabakk NB, Johnsen AC et al. Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Eur J Immunol 1995; 25: 2714-2717.
15. Schumann RR, Lamping N, Kirschning C et al. Lipopolysacharide binding protein: Its role and therapeutical potential in inflammation and sepsis. Biochem Soc Trans 1994; 22: 80-82.
16. Frey EA, Miller DS, Jah TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176: 1665-1671.
17. Eggesbo JB, Hjermann I, Hostmark AT, Kierulf P. LPS induced release of IL-1β, IL-6, IL-8 and TNF-α in EDTA or Heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine 1996; 8: 152-160.
18. Satsangi J, Welsh KI, Bunce M et al. Contribution of genes of the major histocompatobility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1217.
19. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993; 151: 6853.
20. Cassatella MA, Meda L, Bonora S et al. Interleukin 10 (IL-10) inhibits the release of pro-inflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by Iypopolysaccharide. J Exp Med 1993; 178: 2207-2211.
21. Turner DM, Williams DM, Sankaran D et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
22. Crawley E, Kay R, Sillibourne J et al. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukine-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101-1108.
23. Rood MJ, Keijsers V, van der Linden MW et al. Neuropsychiatric systemic lupus erythemathosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis 1999; 58: 85-89.
24. Brattsand R, Linden M. Cytokine modulation by glucocorticoids mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996; 10 (Suppl 2): 91-92.
25. Sutherland LR, Martin F, Greer S et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894-1898.
26. Best WR, Becktel JM, Singelton JW et al. Development of Crohn's disease activity index: National co-operative Crohn's disease study. Gastroenterology 1976; 70: 439-444.
27. Fanning GC, Bunce M, Black CM, Welsh KI. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: Application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin α. Tissue Antigens 1997; 50: 23-31.
28. Koss K, Fanning GC, Jewell DP, Welsh KI. Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3′ mismatches in forward and reverse primers. Genes and Immunity (in press).